Great collaboration with Kevin John 🧪🧩 and Amy Chung on antibodies to COVID in tears and saliva just up on medRxiv. Eye protection everyone! medrxiv.org/content/10.110…

Wonderful zoom meetings of our NHMRC program grant over the last 3 days. Great science and discussion. So fortunate to have the insights of Prof Ranjeny Thomas. Pity we couldn't meet in person but...one day. Jane Batten amazing at keeping us organised.

The Kent lab is hiring! We're looking for a project manager to help co-ordinate our recently funded next-generation COVID-19 clinical vaccine development project 💉 doherty.edu.au/news-events/ne… More information and application below 👇 jobs.unimelb.edu.au/caw/en/job/906…

Congratulations, especially to Adam and the team R

Super proud of Jen, Hyon-Xhi and Amy on the announcement of their NHMRC Investigator awards. Richly deserved in a crazy crazy tough system. Allows them to dream even bigger. Will be exciting to watch over the next 5 years. Congrats Jennifer Juno Hyon-Xhi Amy Chung

Nervous about the ability of new vaccines to combat COVID variants. Our immune systems can recognise the old strains better than the new ones, called "immune imprinting". Discussion piece out in Trends in Immunology. doi.org/10.1016/j.it.2… Adam Wheatley Jennifer Juno Hyon-Xhi

On paper on immune dysfunction during #longCOVID is now publish Nature Immunology. David Darley Daniel Wilson @GregDore2 Kirby Institute, UNSW R Doherty Institute nature.com/articles/s4159…

More brilliant work from David Khoury and team. Elegantly reconciles protective immunity by Nab from multiple angles. Correlates of protection, thresholds of protection, and immunobridging in SARS-CoV-2 infection medrxiv.org/content/10.110…

Our latest preprint shows that neutralising antibodies predict protection from severe COVID-19. Great collaborating with Stephen Kent Megan Steain on this important work from the Kirby Institute, UNSW medrxiv.org/content/10.110…

Crazy strong link between Nab and protection from severe COVID, p <2.2e-16. Superb work by Deborah Cromer, the Davenport group and collaborators. Kirby Institute, UNSW Doherty Institute medrxiv.org/content/10.110…

Research Highlight rdcu.be/c8pFw on a paper by Juno and colleagues that examines T cells frequency and phenotype after Delta and Omicron breakthrough infection in previously vaccinated individuals.

This is super important. Severe COVID is THE major issue today. Neutralising antibodies protect against severe COVID.

Great work team! Yes, keep getting your vaccines people. Although the difference between WT and variant boosters is pretty subtle in some healthy subjects, the variant booster will help some vulnerable groups stay out of hospital.

Strong link between early viral load reduction by anti-COVID treatments and clinical efficacy. Helps rapidly progress better treatments. Bravo, great work by Khoury, Davenport and team. Infection Analytics Program Doherty Institute Kirby Institute, UNSW The Viral and Vaccine Immunology Lab medrxiv.org/content/10.110…